The 2017 USP <800> Compliance Study

 

a National Study of Hazardous Drug Compounding Practices

Study Directors : Eric S Kastango, RPh, MBA, FASHP Kate Douglass, MS, RN, C, CRNI

 

Welcome to
The 2017 USP <800> Compliance Study

 

a National Study of Hazardous Drug Compounding Practices

 

The 2017 USP Chapter <797> & <800> Compliance Study report has been published. To read the full USP <797> report click on the following link and read the article titled: What Prevents Excellence in Sterile Compounding? and to view the results click here The 2017 USP Chapter <797> Compliance Study. The full USP <800> report will be available in PPP Magazine in November 2017.

We would like to thank everyone that participated in this year’s Study. We would also like to thank our sponsors and supporters for helping to make the Study a success.

To use the Gap Analysis Tool during the closed Study time you can click on the Register button below and use the Survey Code H797Z

If you have an active account that was created earlier this year, you can continue to access your survey by logging into the site below with your username and password and make updates to your survey until we begin the 2018 Compliance Study in Spring 2018.

Before you begin your study, we encourage to read the How To Use the Study Tool, view a Sample Report or access to your prior Gap Analysis (if applicable) once you login to your account.

If you have questions or need any assistance, please contact the Study Team at 973-256-6500 or via email at studyteam@797study.com

Log In
To begin, click the Register link below.

Username
Password

Thank you again for your participation in the 2017 USP <800> Compliance Study.


Study Directors